[{"Assets_0_Q2_USD":61641000000.0,"EarningsPerShareBasic_1_Q2_USD":1.26,"EarningsPerShareBasic_2_Q2_USD":3.0,"EarningsPerShareDiluted_1_Q2_USD":1.26,"EarningsPerShareDiluted_2_Q2_USD":2.99,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":5511000000.0,"NetIncomeLoss_1_Q2_USD":1983000000.0,"NetIncomeLoss_2_Q2_USD":4766000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":8278000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":16212000000.0,"StockholdersEquity_0_Q2_USD":-3375000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1572000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1584000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1568000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1579000000.0,"Ticker":"ABBV","CIK":"1551152","name":"ABBVIE INC.","OfficialName":"AbbVie Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"276158647867.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20180807"}]